Cadila, Helperby To Join In R&D For Drugs To Fight Antibiotic Resistance
This article was originally published in PharmAsia News
Cadila Pharmaceuticals and UK-based Helperby Therapeutics have agreed to engage in joint research and development of treatments for infections caused by antibiotic-resistant bacteria.
You may also be interested in...
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.